Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
Pope Leo calls for ‘deep reflection’ about treatment of detained migrants in US
5/11/2025
Intensive livestock farms fail to declare climate impacts in ‘emissions scandal’
5/11/2025
Global stock markets fall sharply over AI bubble fears
5/11/2025
Facebook’s job ads algorithm is sexist, French equality watchdog rules
5/11/2025
Bibi Rukiya’s Restless Daughter review – Lorca’s matriarch sparks tragic dance of desire
5/11/2025
Surge in antisemitism investigations at US universities after October 7 attacks, data shows
5/11/2025